NL7102494A - - Google Patents

Info

Publication number
NL7102494A
NL7102494A NL7102494A NL7102494A NL7102494A NL 7102494 A NL7102494 A NL 7102494A NL 7102494 A NL7102494 A NL 7102494A NL 7102494 A NL7102494 A NL 7102494A NL 7102494 A NL7102494 A NL 7102494A
Authority
NL
Netherlands
Application number
NL7102494A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7102494A publication Critical patent/NL7102494A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
NL7102494A 1970-02-27 1971-02-25 NL7102494A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2009342A DE2009342C3 (de) 1970-02-27 1970-02-27 Verwendung von Glycerin-alkyläther-(l)-phosphorsäure-(3)-monocholinestern

Publications (1)

Publication Number Publication Date
NL7102494A true NL7102494A (cg-RX-API-DMAC7.html) 1971-08-31

Family

ID=5763598

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7102494A NL7102494A (cg-RX-API-DMAC7.html) 1970-02-27 1971-02-25

Country Status (6)

Country Link
BE (1) BE763579A (cg-RX-API-DMAC7.html)
DE (1) DE2009342C3 (cg-RX-API-DMAC7.html)
FR (1) FR2081546B1 (cg-RX-API-DMAC7.html)
GB (1) GB1334137A (cg-RX-API-DMAC7.html)
NL (1) NL7102494A (cg-RX-API-DMAC7.html)
ZA (1) ZA711243B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
DE3131524A1 (de) * 1981-08-08 1983-02-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung physiologischer effektoren
DE3239817A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerinderivate zur synthese von phospholipiden
US5036152A (en) * 1988-03-10 1991-07-30 Hoechst-Roussel Pharmaceuticals Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
US4888328A (en) * 1988-03-10 1989-12-19 Hoeschst-Roussel Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.

Also Published As

Publication number Publication date
FR2081546B1 (cg-RX-API-DMAC7.html) 1974-03-22
FR2081546A1 (cg-RX-API-DMAC7.html) 1971-12-03
DE2009342C3 (de) 1980-12-18
DE2009342A1 (de) 1971-09-02
DE2009342B2 (de) 1980-04-24
BE763579A (fr) 1971-08-26
GB1334137A (en) 1973-10-17
ZA711243B (en) 1971-12-29

Similar Documents

Publication Publication Date Title
FR2173178B2 (cg-RX-API-DMAC7.html)
FR2115701A5 (cg-RX-API-DMAC7.html)
DK142349C (cg-RX-API-DMAC7.html)
FR2108880B1 (cg-RX-API-DMAC7.html)
FR2098190B1 (cg-RX-API-DMAC7.html)
FR2091170A5 (cg-RX-API-DMAC7.html)
DE2101885A1 (cg-RX-API-DMAC7.html)
FR2091648A5 (cg-RX-API-DMAC7.html)
AU442497B2 (cg-RX-API-DMAC7.html)
FR2091375A5 (cg-RX-API-DMAC7.html)
FR2081546B1 (cg-RX-API-DMAC7.html)
FR2098237B1 (cg-RX-API-DMAC7.html)
FR2087919A5 (cg-RX-API-DMAC7.html)
FR2078079A5 (cg-RX-API-DMAC7.html)
FR2094116A1 (cg-RX-API-DMAC7.html)
FR2088583A5 (cg-RX-API-DMAC7.html)
FR2093803A5 (cg-RX-API-DMAC7.html)
DK142469C (cg-RX-API-DMAC7.html)
FR2078089A5 (cg-RX-API-DMAC7.html)
FR2135684A5 (cg-RX-API-DMAC7.html)
FR2075014A5 (cg-RX-API-DMAC7.html)
FR2082326A5 (cg-RX-API-DMAC7.html)
FR2098572A5 (cg-RX-API-DMAC7.html)
FR2106064A5 (cg-RX-API-DMAC7.html)
DE2022077A1 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
BV The patent application has lapsed